 |
Jekk jogħġbok innota li din il-websajt se tkun qed tgħaddi minn xi aġġornamenti din il-ġimgħa. Konsegwentement, l-utenti jistgħu jesperjenzaw instabilità u funzjonalità limitata. Niskużaw ruħna għall-inkonvenjenza.. ("Google tradotta" mill Ingliż oriġinali) |
For a better user experience please update your browser or use Chrome or Firefox browser.
Utilitajiet
Publication detail
Home
Summary of Community decisions on marketing authorizations in respect of medicinal products from 20 November 2005 to 30 November 2005 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)
Summary of Community decisions on marketing authorizations in respect of medicinal products from 20 November 2005 to 30 November 2005 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)
Metadejta tal-pubblikazzjoni
- Ippubblikat:
- Awtur(i) korporattiv(i): Il-Kummissjoni Ewropea
- Suġġett: approvazzjoni ta' bejgħ , leġiżlazzjoni farmaċewtika , prodott mediċinali
- CELEX : 52005XC1230(03)
- OJ : JOC_2005_334_R_0038_01
Viżwalizzatur tad-dokument
Note:
Il-pubblikazzjoni ma tistax tintwera fil-viżwalizzatur tad-dokument. Verżjoni miftuħa fuq l-internet
Tista’ taċċessaha minn: Iddawnlowdjar u lingwi